Hubei Xuanyu Pharmaceutical

Hubei Xuanyu Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is particularly recognized for its expertise in the "Sartan" family of cardiovascular drugs, including Valsartan and Telmisartan. Operating from a modern manufacturing base in Xiangyang, Hubei, the company maintains strict adherence to GMP standards to serve both domestic and international markets. Their portfolio extends beyond cardiovascular health to include antiviral treatments for Hepatitis B and metabolic therapies for Type 2 diabetes. Hubei Xuanyu functions as a key supplier in the global pharmaceutical supply chain, providing high-purity chemical intermediates and generic medications.